Aaron Lazorwitz
· Associate Professor of Obstetrics, Gynecology & Reproductive Sciences; Associate Program Director for Complex Family Planning Fellowship, Obstetrics, Gynecology & Reproductive SciencesVerifiedYale University · Obstetrics, Gynecology, and Reproductive Sciences
Active 2007–2026
About
Aaron Lazorwitz, MD, PhD, is an Associate Professor of Obstetrics, Gynecology & Reproductive Sciences at Yale University, with a dual appointment in the divisions of Family Planning and Reproductive Science. He earned his Bachelor of Arts in psychology from Johns Hopkins University, completed medical school at UT Southwestern Medical Center, and finished his residency and fellowship at the University of Colorado. In 2018, he joined the University of Colorado faculty as a Women's Reproductive Health Research (WRHR) scholar, during which he completed a PhD in Clinical Science. In 2023, Dr. Lazorwitz joined Yale University to help provide comprehensive reproductive healthcare, especially for medically complicated patients, with a focus on a full range of contraceptive options including sterilization. His research interests include understanding how genetic differences influence hormonal contraception, and he spends significant time involved in research activities. Dr. Lazorwitz is passionate about advancing reproductive health and contraception, contributing to the scientific understanding of pharmacogenomic variants, hormonal contraception, and reproductive health counseling.
Research signals
Five dimensions sourced from public faculty / publication signals. Sign in to compare against your own profile and see your match score.
Research topics
- Medicine
- Environmental health
- Family medicine
- Internal medicine
- Gynecology
- Obstetrics
Selected publications
Centenarians’ views and experiences of longevity: a meta-ethnographic systematic review
The Gerontologist · 2026-01-21 · 1 citations
articleBACKGROUND AND OBJECTIVES: Centenarians represent a growing demographic that remains under-theorized in gerontology. Subsumed within the broader category of the oldest old, they are often examined through a biomedical lens, which tends to frame extreme old age as the final stage of decline. While a number of qualitative, interview-based studies have explored centenarians' views and experiences, these accounts have not yet been systematically reviewed or conceptually integrated, leaving a gap in our understanding of this phase of life. This study aimed to synthesize and reinterpret existing qualitative research on centenarians. RESEARCH DESIGN AND METHODS: Through six English-language databases, this meta-ethnography identified and included qualitative studies that captured the first-order constructs of centenarians and the second-order constructs of primary researchers, which informed our third-order interpretations. Study quality was appraised against the CASP Qualitative Checklist, and we followed the 19 steps of the eMERGe reporting guidelines. RESULTS: From 28 included studies, involving a total count of 359 centenarians with potential sample overlap, five lines of argument were constructed: (a) reaching 100 as a continuation of everyday life, (b) resilience shaped by loss, (c) staying connected through people and space, (d) autonomy in physical and mental health, and (e) reconsidering the meaning of life and death after losing loved ones. DISCUSSION AND IMPLICATIONS: Our findings invite a reconsideration of late life as a space of continuous meaning-making, marked by intergenerational connection, resonant loss, and autonomy in care and end-of-life choices. Further research should incorporate centenarians who were not represented in the reviewed studies.
Obstetrics and Gynecology · 2025-05-15
articleSenior authorINTRODUCTION: Many reproductive health services are offered via telehealth, with video and telephone-based options. We conducted a secondary analysis of a cross-sectional study to explore reasons patients chose telephone for their contraceptive counseling visit. METHODS: Patients at a Title X-funded clinic selected their counseling modality (in person or telehealth via Zoom or telephone) when scheduling an appointment for contraception. After counseling, they completed a survey. We compared patients’ reasons for choosing telehealth and comfort with Zoom using bivariate analyses. We inductively coded patients’ free-text responses for why they chose telephone for their visit. RESULTS: From March 2021 to June 2022, 146 patients completed contraceptive counseling and the survey: 44 (30%) video; 102 (70%) telephone. Respondents chose telehealth for similar reasons including convenience and work/school conflicts. Compared to patients choosing telephone, patients choosing video were more likely to already use Zoom for work/school (93.0% versus 69.9%, P =.002) and more likely to be extremely comfortable with Zoom (76.7% versus 57.0%, P =.03). Less than 20% of patients choosing telephone cited a technological barrier to using video. Common themes for choosing phone included convenience, caring for children, not worrying about appearance, multitasking, completing the visit in transit, and that a camera was not necessary for a counseling appointment. CONCLUSIONS/IMPLICATIONS: When given the option, many patients choose telephone for a telehealth appointment, rarely due to technological barriers. Telehealth visits on the telephone may be more conducive to patients’ lifestyle and their preferences. Offering this option for appropriate appointments may improve patients’ satisfaction with their care.
Contraception · 2025-10-18
articleSenior authorAbortion trends in Southern Illinois after the Dobbs vs Jackson Women's Health Organization decision
American Journal of Obstetrics and Gynecology · 2025-06-25 · 1 citations
articleSenior authorContraception · 2025-06-27
articleSenior authorCirculation Research · 2025-03-13 · 2 citations
reviewOpen accessSenior authorCardiovascular disease is the leading cause of maternal mortality in the United States, with the majority of deaths stemming from preventable causes. Contraception is one of the tools that can be utilized to prevent mortality and morbidity associated with unplanned pregnancy in patients with underlying congenital or acquired heart disease. There are a wide range of contraceptive methods available. While some methods, especially those containing estrogen, may be associated with increased risks in certain cardiac disease states, intrauterine devices, implants, and progestin-only methods may be safely used by the vast majority of patients with cardiac disease. Furthermore, intrauterine devices and implants are the most effective reversible contraceptive methods available. This review provides a summary of the US Centers for Disease Control and Prevention 2024 Medical Eligibility Criteria for Contraceptive Use as it applies to cardiac disease states. This review emphasizes the importance of contraceptive counseling and aims to familiarize the reader with the various forms of contraception available to patients, as well as the risks and benefits of each method in patients with different types of cardiac disease.
International Urogynecology Journal · 2025-08-14
articleOpen accessResponse to letter to the Editor
Contraception · 2024-05-11
letterSenior authorQuality of evidence for expulsion rates of copper IUDs
Contraception · 2024-09-13
letterSenior authorContraception · 2024-09-02 · 2 citations
articleSenior author
Frequent coauthors
- 179 shared
Jeffrey F. Peipert
- 146 shared
Gina M. Secura
Washington University in St. Louis
- 90 shared
Jenifer E. Allsworth
- 81 shared
Qiuhong Zhao
- 34 shared
Colleen McNicholas
Planned Parenthood
- 29 shared
David L. Eisenberg
- 27 shared
Rachel Paul
University of Michigan–Ann Arbor
- 22 shared
Christina Buckel
Washington University in St. Louis
Education
B.A., Psychology
Johns Hopkins University
M.D.
not specified
Ph.D.
not specified
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Aaron Lazorwitz
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup